News

Small cap round-up: Portmeirion, Orpak, Medicsight

09 August 2007 14:09:00

Ceramics group Portmeirion said sales in the UK and North America are well ahead of last year, adding that it looks to the future with confidence.

Pre-tax profit rose to £2.49m in the six month to 30 June compared to £713,000 previously on revenue up by 19% to £14.5m. The dividend comes to 3.55p, an increase of 7.6%.

"Growth has been driven by the popularity of our well established ranges such as Botanic Garden and importantly, by the success of the new ranges particularly Sophie Conran," said the group.

Orpak, which provides card-free fuel payment systems, said it has entered the third quarter with a robust order book and looks forward to delivering 'significant' growth during 2007.

Turnover rose 29% to $25.8m in the six months to 30 June. Net profits increased by 35% to $4.1m.

The group said that it is looking for selective acquisitions, adding that it is currently in preliminary discussions for a significant transaction.

Computer aided detection group Medicsight said it is in a strong position to take advantage of the health imaging market.

The group, which made its debut on AIM in June, said it expects to deliver strong growth in both existing and new markets following approvals.

"I have been delighted with progress on all fronts. The contract pipeline is building ahead of schedule, regulatory approvals are on schedule and product development is on track," said chief executive David Sumner.

In the six months to June, pre-tax losses came in at £3.5m compared with 2.6m in the same period last year. It is yet to produce turnover.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.